Global Health Limited · NSE:MEDANTA
Global Health — Q2 FY2024 Earnings Presentation
32 slides from Global Health's earnings presentation, Nov 9, 2023
Slide 1: Exchange filing cover letter for investor presentation
November 9, 2023 Ref:- GHL/2023-24/EXCH/77 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051
Slide 2: Global Health Limited Investor Presentation Q2 FY2024
GLOBAL HEALTH LIMITED Dedicated to Life INVESTOR PRESENTATION 5 Q2 FY2024 1
Slide 3: Contents
Contents 01 Q2 FY2024 Performance Update 02 Medanta: Poised to Deliver Sustainable Growth 03 About Us 2
Slide 4: Q2 FY2024 Performance Update
01 Q2 FY2024 Performance Update 3
Slide 5: Q2 FY2024 performance summary
Q2 FY2024 performance summary Robust performance during the quarter driven by growth in patient volumes INR 8,647 million INR 2,336 million INR 1,252 million Total Income EBITDA and Margins % Margins % PAT and Margin: 27.0% Margin: 14.5% Q2 FY23 Q2 FY23 Q2 FY23 6,946 million 24.5% 1,721 million Marg
Slide 6: Q2 FY2024 performance summary
Q2 FY2024 performance summary Both matured and developing hospitals continue to deliver year on year and sequential growth Consolidated Total Income of INR 8,647 million, grew by 24.5% y-o-y and 8.8% on q-o-q basis. The growth was driven by higher patient volumes across all our facilities, underpinn
Slide 7: Q2 FY2024 performance summary
Q2 FY2024 performance summary Well capitalized balance sheet to drive future expansion plans and growth Key Highlights INR million FY2022 FY2023 H1 FY2024 Gross Debt 8,379 8,422 4,406 • Debt repayment of ~ INR 4,000 million during H1 FY2024 Cash and Cash Equivalents 5,222 13,114 10,447 Net Debt / (N
Slide 8: Q2 FY2024 technology advancement
Q2 FY2024 technology advancement Providing the latest tools to enable our doctors to deliver the greatest care CARL ZEISS - KINEVO 900- The Robotic Visualization System installed at Medanta Gurugram Mobile 8-Slice CT Scanner for bed side patients • Surgeon controlled robotic visualization system ena
Slide 9: Q2 FY2024 clinical achievements
Q2 FY2024 clinical achievements Continuing the legacy of clinical excellence Medanta Gurugram completed over 200 robotic cases during the quarter, one of the highest at single location private hospital Medanta Gurugram lung transplant team flew from Delhi to Junagadh Gujarat, covering over 1,200 kms
Slide 10: Q2 FY2024 key developments
Q2 FY2024 key developments Medanta committed to quality and excellence Dr. Shoibal Mukherjee • Medanta launched Medanta Patna received NABH joined Medanta as Director- “Medanta Clinical accreditation in less than 2 years of its Excellence Program” for Medical Research. He has business operations. MB
Slide 11: Q2 FY2024 key developments
Q2 FY2024 key developments Medanta launched TB Free Program in Uttar Pradesh • Medanta in partnership with the Uttar Pradesh Government has launched “TB Free Uttar Pradesh” to work towards elimination of Tuberculosis in the state • The Memorandum of Understanding (MOU) was signed by Dr. Rakesh Kapoo
Slide 12: Key operating metrics: Revenue and profitability
Key operating metrics: Revenue and profitability Robust growth across all major metrics Total Income (INR million) EBITDA (INR million and margin %) +24.5% +35.7% 8,647 7,945 2,336 6,946 1,993 1,721 Q2 FY23 Q1 FY24 Q2 FY24 Q2 FY23 Q1 FY24 Q2 FY24 24.8% 25.1% 27.0% Profit before tax (INR million and
Slide 13: Key operating metrics: Volumes, occupancies, ALOS
Key operating metrics: Volumes, occupancies, ALOS Strong volume growth, increased bed capacity and improvements in ALOS Average census and occupied beds per day ALOS (days) 2,223 2,223 2,080 3.24 3.14 3.19 1,442 1,224 1,291 Q2 FY23 Q1 FY24 Q2 FY24 Q2 FY23 Q1 FY24 Q2 FY24 59% 58% 65% Census beds Occu
Slide 14: Key operating metrics: ARPOB and revenue mix
Key operating metrics: ARPOB and revenue mix ARPOB growth driven by improved realization ARPOB* (INR) IPD Revenue mix by payor category** +4.8% 63,148 61,003 58,203 63% 62% 61% 24% 3% 24% 4% 24% 4% 8% 2% 8% 2% 9% 2% Q2 FY23 Q1 FY24 Q2 FY24 Q2 FY23 Q1 FY24 Q2 FY24 Cash TPA CGHS/ ECHS/ Indian Railways
Slide 15: Diverse revenue mix
Diverse revenue1 mix Significant contribution from complex specialties Revenue mix by specialty Q2 FY23 Revenue mix by specialty Q2 FY24 18% 20% 23% 23% 4% 3% 5% 8,087 6,548 5% INR million INR million 12% 12% 7% 6% 3 7% 8% 3 12% 12% 11% 11% 3 Heart Digestive Cancer Neuro Kidney & Urology Internal Me
Slide 16: Growth seen in both mature and new hospitals
Growth seen in both mature and new hospitals Volume led growth seen across all units Matured hospitals - Over 6 years Developing hospitals - Less than 6 years Total Income (INR million) EBITDA (INR million and margin %) Total Income (INR million) EBITDA (INR million and margin %) +19.5% +32.8% +40.3
Slide 17: Medanta Poised to Deliver Sustainable Growth
Medanta Poised to Deliver Sustainable Growth 02 Values based growth you can be proud of 16
Slide 18: Medanta is well placed to deliver sustainable growth
Medanta is well placed to deliver sustainable growth… …while maintaining its core values of patient centric care and clinical leadership and quality CONTINUITY OF CARE TECHNOLOGY Extend clinical THOUGHT ADVANCEMENT services outside LEADERSHIP Use technology to hospital and ENHANCE Build on our impro
Slide 19: On-going expansion projects on track for FY2025
On-going expansion projects on track for FY2025 Planned bed capacity addition; well positioned to drive near term growth Number of installed beds Planned growth in number of installed beds 293 2,697 28 2,725 300-550 ~3,500-4,000 191 228 102 150-300 300-350 419 35 2,725 ~100 1,722 410 9 FY 19 FY 20 F
Slide 20: Medanta and DLF to develop ~400 beds super-specialty hospital in Delhi
Medanta and DLF to develop ~400 beds super-specialty hospital in Delhi Further strengthening NCR presence; linking Gurugram and Noida with its new South Delhi facility • Plan to set up a ~400-bed super specialty hospital in South Delhi • GHL and DLF to form a new company, both will contribute equity
Slide 21: On-going expansion projects on track for FY2025
On-going expansion projects on track for FY2025 Noida construction on track with 40% superstructure completion • Project situated in sector 50 Noida, close proximity to metro station • Greenfield project, with bed capacity of 550 beds • Construction started in September 2022 • Substructure – 95% com
Slide 22: About Us
03 About Us 21
Slide 23: Medanta was founded to bring a new type of healthcare to India
Medanta was founded to bring a new type of healthcare to India… … the human side of healthcare Healthcare is never only about science. It is also about the art of medicine – the human connection, putting the patient first, collaboration, the personal acts of empathy and the values that guide our dec
Slide 24: Growth from a single flagship hospital in Gurgaon
Growth from a single flagship hospital in Gurgaon… …to a network of 5 high quality hospitals across north India 2025E MEDANTA HOSPITAL 2021 NOIDA JAI PRABHA Plan for 550 beds 2019 MEDANTA SPECIALTY Expected to MEDANTA HOSPITAL begin phase I 2015 HOSPITAL PATNA operations with MEDANTA ABDUR LUCKNOW ~
Slide 25: One of the largest private hospital chains in North and East India
One of the largest private hospital chains in North and East India Infrastructure and High quality Awards and technology clinical talent accreditations Built to deliver the Full time doctors; National and international most complex care team based care recognition Network of 5 multi- 1,600+ doctors*
Slide 26: From our flagship Medicity campus in Gurgaon, we have grown to ~2,700 beds
From our flagship Medicity campus in Gurgaon, we have grown to ~2,700 beds across 5 cities Largest private hospital beds in operation under one roof in Delhi (NCR), Uttar Pradesh and Bihar GURGAON LUCKNOW PATNA 1,391 beds; 271 ICU beds 601 beds; 202 ICU beds (950 planned) 358 beds; 84 ICU beds (650
Slide 27: Our Mission and Values
Our Mission and Values Embracing a new era and redefining our purpose Core Values Patient centric care: Foster a culture where every one of us is MISSION committed to care for patients and their caregivers Our mission is to deliver Leadership and quality: Commit to delivering excellence in world cla
Slide 28: The Medanta Model of Healthcare
The Medanta Model of Healthcare Delivering the highest quality of medicine with care and compassion Exceptional clinical talent What it means for patients and caregivers? • Super specialized doctors provide the highest quality of care through a team based integrated approach Trust based compassionat
Slide 29: Annexure: Profit and Loss Statement
Annexure: Profit and Loss Statement Half Year End Quarter INR million H1 FY23 H1 FY24 Y-o-Y Growth % Q2 FY23 Q1 FY24 Q2 FY24 Y-o-Y Growth % Revenue from operations 12,965 16,170 24.7% 6,791 7,730 8,439 24.3% Other income 246 422 71.6% 155 215 208 33.8% Total income 13,211 16,592 25.6% 6,946 7,945 8,
Slide 30: Annexure: Operational Parameters
Annexure: Operational Parameters Half Year End Quarter Key metrics H1 FY23 H1 FY24 Y-o-Y Growth % Q2 FY23 Q1 FY24 Q2 FY24 Y-o-Y Growth % Total Beds 2,569 2,725 6.1% 2,569 2,725 2,725 6.1% Average Census Beds 1,973 2,223 12.7% 2,080 2,223 2,223 6.9% Average Occupied Bed Days 213,602 250,066 17.1% 112
Slide 31: Annexure: Abbreviations and Definitions
Annexure: Abbreviations and Definitions Abbreviations INR : Indian Rupee NABH : National Accreditation Board for Hospitals & Healthcare Providers NABL : National Accreditation Board for Testing and Calibration Laboratories JCI : Joint Commission International OPD : Out-Patient Department
Slide 32: Contact us
Contact us About Medanta Contact Details Founded by Dr. Naresh Trehan, a world-renowned cardiovascular and Ravi Gothwal – cardiothoracic surgeon who has been awarded the prestigious Padma Bhushan and the Padma Shri, the third- and fourth-highest Head of Investor Relations civilian awards in India, a